The twin designations are designed to speed up the development and review of promising medicines targeting serious conditions with high unmet need
Collaboration to accelerate mRNA neoantigen therapy development for colorectal and pancreatic cancers using advanced immunology and dark genome insights
After Phase 3 results show major hair regrowth gains
The submission is backed by positive results from the Phase 3 AFFIRM study
His appointment is expected to strengthen scientific input in policy discussions across public health, biotech, and translational research
Denosumab biosimilars approved in Canada to expand access for osteoporosis and cancer-related bone conditions
Once complete, the site will serve as AbbVie’s U.S. center of excellence for SVP manufacturing
While many cases are treatable, a subset can become highly aggressive, spreading to distant organs and resisting conventional therapies
Together, the companies aim to deliver an integrated toolkit for biomarker discovery and clinical research
The newly formed team is led by Tomabu Adjobimey, an immunologist known for his work in host-pathogen interactions and immune modulation
Subscribe To Our Newsletter & Stay Updated
